Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma

NCT00193297 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Ovary Cancer

Interventions

DRUG: Topotecan
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]